Taka E - Search Results

1

The attenuation of early benzo(a)pyrene-induced carcinogenic insults by diallyl disulfide (DADS) in MCF-10A cells.

Nkrumah-Elie YM, Reuben JS, Hudson AM, Taka E, Badisa R, Ardley T, Israel B, Sadrud-Din SY, Oriaku ET, Darling-Reed SF. Nkrumah-Elie YM, et al. Among authors: taka e. Nutr Cancer. 2012;64(7):1112-21. doi: 10.1080/01635581.2012.712738. Epub 2012 Sep 24. Nutr Cancer. 2012. PMID: 23006051 Free PMC article.

2

Diallyl trisulfide as an inhibitor of benzo(a)pyrene-induced precancerous carcinogenesis in MCF-10A cells.

Nkrumah-Elie YM, Reuben JS, Hudson A, Taka E, Badisa R, Ardley T, Israel B, Sadrud-Din SY, Oriaku E, Darling-Reed SF. Nkrumah-Elie YM, et al. Among authors: taka e. Food Chem Toxicol. 2012 Jul;50(7):2524-30. doi: 10.1016/j.fct.2012.04.010. Epub 2012 Apr 16. Food Chem Toxicol. 2012. PMID: 22525868 Free PMC article.

3

Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.

Bauer D, Mazzio E, Soliman KF, Taka E, Oriaku E, Womble T, Darling-Reed S. Bauer D, et al. Among authors: taka e. Anticancer Res. 2014 Jun;34(6):2763-70. Anticancer Res. 2014. PMID: 24922637 Free PMC article.

4

Comparative proteomic analysis reveals growth inhibition by 3-N-alkyloxyestradiol derivative (SERM) in prostate cancer cells.

Green JE, Cooperwood JS, Taka E, Soliman KF, Goodman CB, Reams RR. Green JE, et al. Among authors: taka e. Cancer Genomics Proteomics. 2014 Jul-Aug;11(4):195-200. Cancer Genomics Proteomics. 2014. PMID: 25048348 Free PMC article.

5

Diallyl disulfide inhibits TNFα induced CCL2 release through MAPK/ERK and NF-Kappa-B signaling.

Bauer D, Redmon N, Mazzio E, Taka E, Reuben JS, Day A, Sadrud-Din S, Flores-Rozas H, Soliman KF, Darling-Reed S. Bauer D, et al. Among authors: taka e. Cytokine. 2015 Sep;75(1):117-26. doi: 10.1016/j.cyto.2014.12.007. Epub 2015 Jun 20. Cytokine. 2015. PMID: 26100848 Free PMC article.

6

Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.

Taka E, Mazzio EA, Goodman CB, Redmon N, Flores-Rozas H, Reams R, Darling-Reed S, Soliman KF. Taka E, et al. J Neuroimmunol. 2015 Sep 15;286:5-12. doi: 10.1016/j.jneuroim.2015.06.011. Epub 2015 Jun 27. J Neuroimmunol. 2015. PMID: 26298318 Free PMC article.

7

Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment.

Adinew GM, Taka E, Mochona B, Badisa RB, Mazzio EA, Elhag R, Soliman KFA. Adinew GM, et al. Among authors: taka e. Nutrients. 2021 Dec 25;14(1):79. doi: 10.3390/nu14010079. Nutrients. 2021. PMID: 35010954 Free PMC article. Review.

8

Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.

Adinew GM, Messeha SS, Taka E, Badisa RB, Antonie LM, Soliman KFA. Adinew GM, et al. Among authors: taka e. Nutrients. 2022 May 19;14(10):2120. doi: 10.3390/nu14102120. Nutrients. 2022. PMID: 35631261 Free PMC article.

9

Thymoquinone Anticancer Effects Through the Upregulation of NRF2 and the Downregulation of PD-L1 in MDA-MB-231 Triple-Negative Breast Cancer Cells.

Adinew G, Messeha SS, Badisa R, Taka E, Soliman KFA. Adinew G, et al. Among authors: taka e. FASEB J. 2022 May;36 Suppl 1. doi: 10.1096/fasebj.2022.36.S1.R2586. FASEB J. 2022. PMID: 35723877

10

Anticancer Effects of Thymoquinone through the Antioxidant Activity, Upregulation of Nrf2, and Downregulation of PD-L1 in Triple-Negative Breast Cancer Cells.

Adinew GM, Messeha SS, Taka E, Badisa RB, Soliman KFA. Adinew GM, et al. Among authors: taka e. Nutrients. 2022 Nov 13;14(22):4787. doi: 10.3390/nu14224787. Nutrients. 2022. PMID: 36432484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters